Evaluation of a new device for bypassing blockages in colorectal cancer patients
Evaluation of CG-100 Intraluminal Bypass Device
This study is testing a new device that helps people with colorectal cancer get around blockages in their intestines to see if it works well and is safe.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 10 (estimated) |
| Ages | 22 Years to 75 Years |
| Sex | All |
| Sponsor | Colospan Ltd. Industry-sponsored |
| Locations | 1 site (Reẖovot) |
| Trial ID | NCT05632744 on ClinicalTrials.gov |
What this trial studies
This study evaluates the CG-100 Intraluminal Bypass Device, designed to assist patients with colorectal cancer by providing a new method to bypass obstructions. The trial will involve pre-operative patients who meet specific eligibility criteria, including age and diagnosis. Participants will be monitored for compliance with follow-up evaluations to assess the device's effectiveness and safety. The study aims to gather data on the device's performance in a clinical setting.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 22 to 75 who have been diagnosed with colorectal cancer and are willing to comply with follow-up evaluations.
Not a fit: Patients outside the age range of 22 to 75 or those not diagnosed with colorectal cancer may not receive any benefit from this study.
Why it matters
Potential benefit: If successful, this device could improve the quality of life and treatment outcomes for patients with colorectal cancer by providing an effective means to manage obstructions.
How similar studies have performed: While this specific device is novel, similar approaches in managing colorectal obstructions have shown promise in other studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria (pre-operative): 1. Willing to comply with protocol-specified follow-up evaluations 2. 22-75 (inclusive) years of age at screening 3. Diagnosed with colorectal cancer 4. Has been informed of the nature of the study, agrees to its provisions, and has provided written informed consent
Where this trial is running
Reẖovot
- Soroka Medical Center — Reẖovot, Israel (Recruiting)
Study contacts
- Study coordinator: Shelly Sharon
- Email: shelly@colospan.com
- Phone: +972-50-2988415
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.